Related content

Quality of Life in Oncology Practice: Prognostic Value of EORTC QLQ-C30 Scores in Patients with Advanced Malignancy

By Coates A.   Porzsolt F.   Osoba D.  

European Journal of Cancer, Vol. 33, Iss. 7, 1997-06 ,pp. : 1025-1030

Elsevier

Access to resources Recommend Favorite

The Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study

By Hernandez E.   Donohue K.A.   Anderson L.L.   Heller P.B.   Stehman F.B.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study

By Ball H.G.   Blessing J.A.   Lentz S.S.   Mutch D.G.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 278-281

Academic Press

Access to resources Recommend Favorite

Phase II study of Ifosfamide+Doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the Eastern Cooperative Oncology Group

By Edmonson John H.   Ryan Louise M.   Falkson Carla I.   Hicks David G.   Blum Ronald H.  

Sarcoma, Vol. 7, Iss. 1, 2003-01 ,pp. : 9-11

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Topotecan in Patients with Advanced, Persistent, or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

By Miller D.S.   Blessing J.A.   Lentz S.S.   Waggoner S.E.  

Gynecologic Oncology, Vol. 87, Iss. 3, 2002-12 ,pp. : 247-251

Academic Press

Access to resources Recommend Favorite